Eisai's drug for Alzheimer's with Biogen gets breakthrough status in US

·

·

Eisai's drug for Alzheimer's with Biogen gets breakthrough status in US

June 23 (Reuters) – Japanese company Eisai Co (4523.T) and partner Biogen Inc (BIIB.O) said on Wednesday the U.S. Food and Drug Administration had granted breakthrough therapy designation to their experimental therapy, lecanemab, for patients with …
See Original Article

This finance and accounting graduate is now an IT auditor, despite having no background in the field

Initially, the accounting and finance graduate from the Singapore campus of James Cook University (JCU) thought his interest lay in finance audit. Four
See Original Article

The real feat of Microsoft's $2 trillion milestone

The company brought in $143 billion in revenue last year, about half from renting access to its Azure computer servers and Office 365 software, among other cloud services. To the folks in Redmond, Wash., the era of shrink-wrapped boxes of CD-ROMs is but a …
See Original Article

Bill Ackman eyes US listing for Universal, expects to close next deal soon

BOSTON, June 23 (Reuters) – William Ackman, whose blank check acquisition company struck a deal to buy 10% of Universal Music Group (UMG) last week, is exploring options to increase his stake in the music label and expects to close his next deal soon, …
See Original Article

Torchlight Energy, a Recent Favorite Among Individual Investors, Extends Tumble

The Dow and S&P 500 edged lower, while Nasdaq inched higher to a new record close. Crude oil and bitcoin recovered, while lumber continued to fall. Jun 23, 2021 at …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.